Senkyunolide I

CAS No. 94596-28-8

Senkyunolide I( Senkyunolide I | Ligustilidiol, (Z)- | Ligustilidiol )

Catalog No. M19281 CAS No. 94596-28-8

Senkyunolide I has neuroprotective effect, associated with its anti-oxidation and anti-apoptosis properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 86 In Stock
5MG 77 In Stock
10MG 104 In Stock
25MG 155 In Stock
50MG 230 In Stock
100MG 352 In Stock
200MG 520 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Senkyunolide I
  • Note
    Research use only, not for human use.
  • Brief Description
    Senkyunolide I has neuroprotective effect, associated with its anti-oxidation and anti-apoptosis properties.
  • Description
    Senkyunolide I has antioxidant and anti-migraine activities; isolated from Ligusticum chuanxiong.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Senkyunolide I | Ligustilidiol, (Z)- | Ligustilidiol
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    94596-28-8
  • Formula Weight
    224.25
  • Molecular Formula
    C12H16O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (445.93 mM)
  • SMILES
    CCCC=C1C2=C(C(C(CC2)O)O)C(=O)O1
  • Chemical Name
    (6R,7R,Z)-3-butylidene-6,7-dihydroxy-4,5,6,7-tetrahydroisobenzofuran-1(3H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • POPS

    POPS is a useful organic compound for research related to life sciences. The catalog number is TF0061 and the CAS number is 321863-21-2.

  • Fluensulfone

    Fluensulfone is a new nematicide of the fluoroalkenyl thioether group that has significantly reduced environmental impact with low toxicity to non-target insects and mammals.

  • L-Theanine

    L-Theanine, extracted from Camellia sinensis, is under investigation in clinical trial NCT00291070 (Effects of L-Theanine in Boys With ADHD).